Home > JCR > Journal > Abstract > Vol.22 No.4
Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
Shumpei Yokota, Tomoyuki Imagawa, Takuji Murata, Minako Tomiita, Yasuhiko Itoh, Satoshi Fujikawa, Syuji Takei, Masaaki Mori
P.491-497
10.1007/s10165-011-0561-1
Abstract
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Shuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka
P.498-508
10.1007/s10165-011-0541-5
Abstract
Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases
Yuji Yoshida, Yuko Takahashi, Nobuyoshi Minemura, Yo Ueda, Hiroyuki Yamashita, Hiroshi Kaneko, Akio Mimori
P.509-514
10.1007/s10165-011-0523-7
Abstract
Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms
Shunsuke Mori, Kaoru Terada, Yukitaka Ueki
P.515-523
10.1007/s10165-011-0537-1
Abstract
Smoking is associated with an increased risk of developing ACPA-positive but not ACPA-negative rheumatoid arthritis in Asian populations: evidence from the Malaysian MyEIRA case-control study
Abqariyah Yahya, Camilla Bengtsson, Too Chun Lai, Per T. Larsson, Amal Nasir Mustafa, Nor Aini Abdullah, Norasiah Muhamad, Heselynn Hussein, Lars Klareskog, Lars Alfredsson, Shahnaz Murad
P.524-531
10.1007/s10165-011-0544-2
Abstract
Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis
Motoaki Hoshino, Taku Yoshio, Sachiko Onishi, Seiji Minota
P.532-540
10.1007/s10165-011-0567-8
Abstract
Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL
Takumi Furuya, Minori Koga, Koki Hikami, Aya Kawasaki, Naoyuki Tsuchiya
P.541-549
10.1007/s10165-011-0539-z
Abstract
Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis
Jing Li, Jin-Hui Tao, Wei Gao, Ye Fan, Man-Man Lu, Rui Li, Xiang-Pei Li, Dong-Qing Ye
P.550-556
10.1007/s10165-011-0573-x
Abstract
Erratum to: Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis
Jing Li, Jin-Hui Tao, Wei Gao, Ye Fan, Man-Man Lu, Rui Li, Xiang-Pei Li, Dong-Qing Ye
P.557
10.1007/s10165-012-0669-y
Abstract
Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis
Remi Ozawa, Yutaka Inaba, Masaaki Mori, Ryoki Hara, Masako Kikuchi, Rumiko Higuchi, Takako Miyamae, Tomoyuki Imagawa, Takeo Fujiwara, Tomoyuki Saito, Shumpei Yokota
P.558-564
10.1007/s10165-011-0540-6
Abstract
Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab
Jun-ichi Kawada, Naomi Iwata, Yoshiro Kitagawa, Hiroshi Kimura, Yoshinori Ito
P.565-570
10.1007/s10165-011-0552-2
Abstract
The role of resistin in Behçet’s disease: a Turkish experiment
Yavuz Pehlivan, Ahmet Mesut Onat, Seydi Okumus, Bunyamin Kisacik, Gazi Comez, Aysegul Comez, Fatih Goktepe, Nurdan Ozlu Ceylan
P.571-575
10.1007/s10165-011-0546-0
Abstract
Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis
Naohiko Aozasa, Yoshihide Asano, Kaname Akamata, Shinji Noda, Yuri Masui, Zenshiro Tamaki, Yayoi Tada, Makoto Sugaya, Takafumi Kadono, Shinichi Sato
P.576-583
10.1007/s10165-011-0553-1
Abstract
High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome
Tomoki Origuchi, Kazuhiko Arima, Shin-ya Kawashiri, Mami Tamai, Satoshi Yamasaki, Hideki Nakamura, Toshiaki Tsukada, Toshiyuki Aramaki, Masako Furuyama, Taiichiro Miyashita, Yojiro Kawabe, Nozomi Iwanaga8, Kaoru Terada8, Yukitaka Ueki8, Takaaki Fukuda9, Katsumi Eguchi10, Atsushi Kawakami
P.584-588
10.1007/s10165-011-0556-y
Abstract
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
Shigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, Aileen L. Pangan, Shringi Sharma, L. Steven Brown, Nobuyuki Miyasaka
P.589-597
10.1007/s10165-011-0557-x
Abstract
Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases
Takehiro Takahashi, Yoshihide Asano, Eisuke Amiya, Masaru Hatano, Zenshiro Tamaki, Atsuko Ozeki, Aya Watanabe, Shuichi Kawarasaki, Tomoko Nakao, Takashi Taniguchi, Yohei Ichimura, Tetsuo Toyama1, Masafumi Watanabe2, Yasunobu Hirata2, Ryozo Nagai2, Shinichi Sato
P.598-601
10.1007/s10165-011-0545-1
Abstract
Morphea associated with the use of adalimumab: a case report and review of the literature
Julio Ramírez, M. Victoria Hernández, Javier Galve, Juan D. Cañete, Raimon Sanmartí
P.602-604
10.1007/s10165-011-0550-4
Abstract
Positional occlusion of the vertebral artery in a case of rheumatoid atlantoaxial subluxation presenting with multiple cerebral and cerebellar infarction
Hiroyasu Fujiwara, Takashi Kaito, Takahiro Makino, Kazuo Yonenobu
P.605-609
10.1007/s10165-011-0547-z
Abstract
Three cases of pneumatosis intestinalis presenting in autoimmune diseases
Akihiro Sagara, Kiyoki Kitagawa, Kengo Furuichi, Shinji Kitajima, Tadashi Toyama, Toshiya Okumura, Akinori Hara, Yoshio Sakai, Shuichi Kaneko, Takashi Wada
P.610-615
10.1007/s10165-011-0551-3
Abstract
Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener’s)
Azusa Umemoto, Hidekazu Ikeuchi, Keiju Hiromura, Hiroko Hamatani, Noriyuki Sakurai, Toru Sakairi, Takayuki Matsumoto, Akito Maeshima, Takashi Kuroiwa, Yoshihisa Nojima
P.616-620
10.1007/s10165-011-0554-0
Abstract
Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab
Shunichiro Takezaki, Yuka Okura, Mizuho Ichikawa, Daisuke Suzuki, Junjiro Ohshima, Makoto Kaneda, Yuko Cho, Masafumi Yamada, Nobuaki Kawamura, Akihiro Iguchi, Ichiro Kobayashi, Tadashi Ariga
P.621-624
10.1007/s10165-011-0555-z
Abstract
Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies
Shinji Sato, Masataka Kuwana, Takashi Fujita, Yasuo Suzuki
P.625-629
10.1007/s10165-011-0558-9
Abstract
The rapid efficacy of abatacept in a patient with rheumatoid vasculitis
Wataru Fujii, Masataka Kohno, Hidetaka Ishino, Amane Nakabayashi, Kazuki Fujioka, Takashi Kida, Hidetake Nagahara, Ken Murakami, Kaoru Nakamura, Takahiro Seno, Aihiro Yamamoto, Yutaka Kawahito
P.630-634
10.1007/s10165-011-0559-8
Abstract
Radiographic remodeling of the shoulder joint in a patient with rheumatoid arthritis after 4 years of treatment with etanercept
Toshifumi Ozaki, Kenzo Hashizume, Ryuichi Nakahara, Keiichiro Nishida
P.635-637
10.1007/s10165-012-0599-8
Abstract
Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.
Takao Nagashima, Hitoaki Okazaki, Yasuyuki Kamata, Seiji Minota
P.638-639
10.1007/s10165-012-0676-z
Abstract
Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.
Isamu Yokoe, Shinya Nishio, Hiroshi Sato, Hitomi Kobayashi
P.640-642
10.1007/s10165-012-0677-y
Abstract
Erratum to: Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.
Isamu Yokoe, Shinya Nishio, Hiroshi Sato, Hitomi Kobayashi
P.643
10.1007/s10165-012-0719-5
Abstract